Accellacare - Raleigh — Raleigh, North Carolina

Accellacare - Raleigh is a clinical research site located in Raleigh, North Carolina, United States 27609.

Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.

Accellacare - Raleigh has participated in 11 clinical trials with 5 currently active.

Therapeutic areas: Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a), Atopic Dermatitis.

Sponsors: Eli Lilly and Company, Biosion, Inc., Vaxart.

Sponsor Feasibility Report

Trust Score: 76/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Accellacare - Raleigh?

Accellacare - Raleigh has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Accellacare - Raleigh conducted?

Accellacare - Raleigh has 11 clinical trials on record, with 5 currently active. Their work covers Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a), Atopic Dermatitis.

Is Accellacare - Raleigh accredited by Crixeo Health?

Yes — Accellacare - Raleigh holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Accellacare - Raleigh?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.